INS and neoplasm: Cell-autonomous Akt2 ablation inhibited primary tumour formation whereas germline or inducible systemic deletion of Akt2 enhanced tumour development [25,26] via elevated circulating insulin levels leading to hyperactivation of AKT1 [26].